Keywords: intermune, highlight, anti-fibrotic, pipeline, ats, usa-based, announced

InterMune to highlight anti-fibrotic pipeline at ATS

Article | 20 May 2002

USA-based InterMune has announced that data and abstracts related to its"promising pipeline of anti-fibrotic therapeutics" will be presented at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Actimmune

Interferon Gamma 1 b

Go to drug listing